Safety and Efficacy of Neoadjuvant Gemcitabine plus Carboplatin Followed by Immediate Cystectomy in Patients with Muscle-Invasive Bladder Cancer: A Propensity Score Analysis

被引：0
|
作者：
Koie, T. [1 ]
Okamoto, A. [1 ]
Tobisawa, Y. [1 ]
Yoneyama, T. [1 ]
Mori, K. [1 ]
Yamamoto, H. [1 ]
Hatakeyama, S. [1 ]
Yoneyama, T. [1 ]
Hashimoto, Y. [1 ]
Ohyama, C. [1 ]
机构：
[1] Hirosaki Univ, Grad Sch Med, Dept Urol, Hirosaki, Aomori, Japan
来源：
UROLOGY | 2012年 / 80卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
EP.044
引用
收藏
页码：S205 / S205
页数：1
相关论文
共 50 条
  • [21] Is neoadjuvant chemotherapy with gemcitabine plus cisplatin beneficial in patients with muscle-invasive bladder cancer?
    Yafi, Faysal A.
    Kassouf, Wassim
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 747 - 752
  • [22] Efficacy and safety analysis of neoadjuvant chemotherapy combined with immunotherapy in patients with muscle-invasive bladder cancer
    Yu, Yanhang
    Zhang, Chuanao
    Chen, Hao
    Zhang, Jianglei
    Ouyang, Jun
    Zhang, Zhiyu
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [23] Editorial Comment to "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Kikuchi, Eiji
    Hayakawa, Nozomi
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1106 - 1106
  • [24] Editorial Comment on "Efficacy and safety of dose-dense gemcitabine plus cisplatin as neoadjuvant chemotherapy for muscle-invasive bladder cancer"
    Urabe, Fumihiko
    Suzuki, Hirotaka
    Iwatani, Kosuke
    Kimura, Takahiro
    INTERNATIONAL JOURNAL OF UROLOGY, 2024, 31 (10) : 1107 - 1107
  • [25] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
    Xing, N.
    Han, S.
    Jiang, J.
    Xu, W.
    Shi, B.
    Ping, H.
    Ji, Z.
    Ma, Q.
    Wang, H.
    Chen, S.
    Wang, W.
    Fan, X.
    Zhou, Q.
    Zhang, W.
    ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
  • [26] Retrospective Analysis of the Efficacy of Two Cycles of M-VAC Neoadjuvant Chemotherapy Followed by Radical Cystectomy for Muscle-invasive Bladder Cancer
    Kitagawa, Yasuhide
    Izumi, Komi
    Miwa, Sotaro
    Kadono, Yoshifumi
    Konaka, Hiroyuki
    Mizokami, Atsushi
    Namiki, Mikio
    ANTICANCER RESEARCH, 2013, 33 (10) : 4497 - 4503
  • [27] PROPENSITY SCORE MATCHED SURVIVAL ANALYSIS OF OCTOGENARIANS WITH MUSCLE-INVASIVE BLADDER CANCER: CHEMORADIATION COMPARED TO RADICAL CYSTECTOMY
    Prabhakar, Pushan
    Ganapathi, Hariharan
    Kulkarni, Nikhil
    Eldefrawy, Ahmed
    Caso, Jorge
    Manoharan, Murugesan
    JOURNAL OF UROLOGY, 2023, 209 : E779 - E779
  • [28] Propensity score matched survival analysis of octogenarians with muscle-invasive bladder cancer: chemoradiation compared to radical cystectomy
    Avudaiappan, Arjun Pon
    Prabhakar, Pushan
    Ganapathi, Hariharan
    VanderVeer-Harris, Nathan
    Caso, Jorge
    Garje, Rohan
    Manoharan, Murugesan
    CANADIAN JOURNAL OF UROLOGY, 2023, 30 (05) : 11686 - 11691
  • [29] Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
    Koie, Takuya
    Ohyama, Chikara
    Yamamoto, Hayato
    Imai, Atsushi
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Yoneyama, Tohru
    Tobisawa, Yuki
    MEDICAL ONCOLOGY, 2014, 31 (05)
  • [30] Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
    Takuya Koie
    Chikara Ohyama
    Hayato Yamamoto
    Atsushi Imai
    Shingo Hatakeyama
    Takahiro Yoneyama
    Yasuhiro Hashimoto
    Tohru Yoneyama
    Yuki Tobisawa
    Medical Oncology, 2014, 31
12345